HEADER    ANTAGONIST                              28-JUL-95   1BDK              
TITLE     AN NMR, CD, MOLECULAR DYNAMICS, AND FLUOROMETRIC STUDY OF THE         
TITLE    2 CONFORMATION OF THE BRADYKININ ANTAGONIST B-9340 IN WATER AND IN     
TITLE    3 AQUEOUS MICELLAR SOLUTIONS                                           
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: BRADYKININ ANTAGONIST B-9340;                              
COMPND   3 CHAIN: A;                                                            
COMPND   4 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES                                                       
KEYWDS    BRADYKININ ANTAGONIST, ANTAGONIST                                     
EXPDTA    SOLUTION NMR                                                          
AUTHOR    J.SEJBAL,G.KOTOVYCH,J.R.CANN,J.M.STEWART,L.GERA                       
REVDAT   4   05-JUN-24 1BDK    1       REMARK LINK                              
REVDAT   3   13-JUL-11 1BDK    1       VERSN                                    
REVDAT   2   24-FEB-09 1BDK    1       VERSN                                    
REVDAT   1   07-DEC-95 1BDK    0                                                
JRNL        AUTH   J.SEJBAL,J.R.CANN,J.M.STEWART,L.GERA,G.KOTOVYCH              
JRNL        TITL   AN NMR, CD, MOLECULAR DYNAMICS, AND FLUOROMETRIC STUDY OF    
JRNL        TITL 2 THE CONFORMATION OF THE BRADYKININ ANTAGONIST B-9340 IN      
JRNL        TITL 3 WATER AND IN AQUEOUS MICELLAR SOLUTIONS.                     
JRNL        REF    J.MED.CHEM.                   V.  39  1281 1996              
JRNL        REFN                   ISSN 0022-2623                               
JRNL        PMID   8632435                                                      
JRNL        DOI    10.1021/JM950485F                                            
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   W.GUBA,R.HAESSNER,G.BREIPOHL,S.HENKE,J.KNOLLE,V.SANTAGADA,   
REMARK   1  AUTH 2 H.KESSLER                                                    
REMARK   1  TITL   COMBINED APPROACH OF NMR AND MOLECULAR DYNAMICS WITHIN A     
REMARK   1  TITL 2 BIPHASIC MEMBRANE MIMETICS: CONFORMATION AND ORIENTATION OF  
REMARK   1  TITL 3 THE BRADYKININ ANTAGONIST HOE 140                            
REMARK   1  REF    J.AM.CHEM.SOC.                V. 116  7532 1994              
REMARK   1  REFN                   ISSN 0002-7863                               
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : BIOGRAF                                              
REMARK   3   AUTHORS     : MOLECULAR SIMULATIONS,INC                            
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1BDK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.                                
REMARK 100 THE DEPOSITION ID IS D_1000171626.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : NULL                               
REMARK 210  PH                             : NULL                               
REMARK 210  IONIC STRENGTH                 : NULL                               
REMARK 210  PRESSURE                       : NULL                               
REMARK 210  SAMPLE CONTENTS                : NULL                               
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : NULL                               
REMARK 210  SPECTROMETER FIELD STRENGTH    : NULL                               
REMARK 210  SPECTROMETER MODEL             : NULL                               
REMARK 210  SPECTROMETER MANUFACTURER      : NULL                               
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NULL                               
REMARK 210   METHOD USED                   : NULL                               
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : NULL                               
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 1                                  
REMARK 210 CONFORMERS, SELECTION CRITERIA  : NULL                               
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL                
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    DAR A   1   NE  -  CZ  -  NH1 ANGL. DEV. =   7.9 DEGREES          
REMARK 500    DAR A   1   NE  -  CZ  -  NH2 ANGL. DEV. =  -6.9 DEGREES          
REMARK 500    ARG A   2   NE  -  CZ  -  NH1 ANGL. DEV. =   4.4 DEGREES          
REMARK 500    ARG A   2   NE  -  CZ  -  NH2 ANGL. DEV. =  -6.0 DEGREES          
REMARK 500    ARG A  10   NE  -  CZ  -  NH1 ANGL. DEV. =   4.6 DEGREES          
REMARK 500    ARG A  10   NE  -  CZ  -  NH2 ANGL. DEV. =  -3.1 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    PRO A   3      104.86    -32.35                                   
REMARK 500    TIH A   6      119.46    173.60                                   
REMARK 500    IGL A   8     -157.12     81.17                                   
REMARK 500    OIC A   9       59.25    -93.07                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS                                         
REMARK 500                                                                      
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH          
REMARK 500 CIS AND TRANS CONFORMATION.  CIS BONDS, IF ANY, ARE LISTED           
REMARK 500 ON CISPEP RECORDS.  TRANS IS DEFINED AS 180 +/- 30 AND               
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.                                  
REMARK 500                                 MODEL     OMEGA                      
REMARK 500 GLY A    5     TIH A    6                  149.02                    
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DAR A 1                   
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OIC A 9                   
DBREF  1BDK A    1    10  PDB    1BDK     1BDK             1     10             
SEQRES   1 A   10  DAR ARG PRO HYP GLY TIH SER IGL OIC ARG                      
MODRES 1BDK HYP A    4  PRO  4-HYDROXYPROLINE                                   
MODRES 1BDK TIH A    6  ALA  BETA(2-THIENYL)ALANINE                             
MODRES 1BDK IGL A    8  GLY  ALPHA-AMINO-2-INDANACETIC ACID                     
HET    DAR  A   1      26                                                       
HET    HYP  A   4      15                                                       
HET    TIH  A   6      17                                                       
HET    IGL  A   8      24                                                       
HET    OIC  A   9      24                                                       
HETNAM     DAR D-ARGININE                                                       
HETNAM     HYP 4-HYDROXYPROLINE                                                 
HETNAM     TIH BETA(2-THIENYL)ALANINE                                           
HETNAM     IGL ALPHA-AMINO-2-INDANACETIC ACID                                   
HETNAM     OIC OCTAHYDROINDOLE-2-CARBOXYLIC ACID                                
HETSYN     HYP HYDROXYPROLINE                                                   
FORMUL   1  DAR    C6 H15 N4 O2 1+                                              
FORMUL   1  HYP    C5 H9 N O3                                                   
FORMUL   1  TIH    C7 H9 N O2 S                                                 
FORMUL   1  IGL    C11 H13 N O2                                                 
FORMUL   1  OIC    C9 H15 N O2                                                  
LINK         C   DAR A   1                 N   ARG A   2     1555   1555  1.36  
LINK         C   PRO A   3                 N   HYP A   4     1555   1555  1.37  
LINK         C   HYP A   4                 N   GLY A   5     1555   1555  1.34  
LINK         C   GLY A   5                 N   TIH A   6     1555   1555  1.35  
LINK         C   TIH A   6                 N   SER A   7     1555   1555  1.36  
LINK         C   SER A   7                 N   IGL A   8     1555   1555  1.35  
LINK         C   IGL A   8                 N   OIC A   9     1555   1555  1.38  
LINK         C   OIC A   9                 N   ARG A  10     1555   1555  1.36  
SITE     1 AC1  2 ARG A   2  PRO A   3                                          
SITE     1 AC2  3 TIH A   6  SER A   7  IGL A   8                               
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
HETATM    1  N   DAR A   1       2.926  -5.879  -6.718  1.00  0.00           N  
HETATM    2  CA  DAR A   1       1.873  -6.196  -5.715  1.00  0.00           C  
HETATM    3  CB  DAR A   1       0.674  -6.777  -6.518  1.00  0.00           C  
HETATM    4  CG  DAR A   1      -0.485  -7.382  -5.667  1.00  0.00           C  
HETATM    5  CD  DAR A   1      -0.099  -8.646  -4.858  1.00  0.00           C  
HETATM    6  NE  DAR A   1      -1.289  -9.163  -4.264  1.00  0.00           N  
HETATM    7  CZ  DAR A   1      -1.681  -9.128  -2.986  1.00  0.00           C  
HETATM    8  NH1 DAR A   1      -1.044  -8.602  -1.946  1.00  0.00           N  
HETATM    9  NH2 DAR A   1      -2.852  -9.695  -2.783  1.00  0.00           N  
HETATM   10  C   DAR A   1       1.538  -4.977  -4.917  1.00  0.00           C  
HETATM   11  O   DAR A   1       1.241  -3.938  -5.559  1.00  0.00           O  
HETATM   12  H1  DAR A   1       2.653  -5.053  -7.264  1.00  0.00           H  
HETATM   13  H2  DAR A   1       3.813  -5.657  -6.253  1.00  0.00           H  
HETATM   14  H3  DAR A   1       3.088  -6.637  -7.375  1.00  0.00           H  
HETATM   15  HA  DAR A   1       2.265  -6.960  -5.035  1.00  0.00           H  
HETATM   16  HB2 DAR A   1       0.280  -5.971  -7.151  1.00  0.00           H  
HETATM   17  HB3 DAR A   1       1.046  -7.555  -7.196  1.00  0.00           H  
HETATM   18  HG2 DAR A   1      -0.895  -6.636  -4.977  1.00  0.00           H  
HETATM   19  HG3 DAR A   1      -1.304  -7.655  -6.345  1.00  0.00           H  
HETATM   20  HD2 DAR A   1       0.336  -9.407  -5.515  1.00  0.00           H  
HETATM   21  HD3 DAR A   1       0.644  -8.416  -4.095  1.00  0.00           H  
HETATM   22  HE  DAR A   1      -1.948  -9.590  -4.824  1.00  0.00           H  
HETATM   23 HH11 DAR A   1      -0.183  -8.193  -2.046  1.00  0.00           H  
HETATM   24 HH12 DAR A   1      -1.416  -8.685  -1.063  1.00  0.00           H  
HETATM   25 HH21 DAR A   1      -3.278 -10.092  -3.546  1.00  0.00           H  
HETATM   26 HH22 DAR A   1      -3.255  -9.688  -1.910  1.00  0.00           H